Walleye Trading
TEVA icon

Walleye Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Walleye Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.5M Buy
2,109,000
+299,700
+17% +$9.64M 0.11% 196
2025
Q4 		$56.5M Sell
1,809,300
-454,100
-20% -$11.2M 0.08% 251
2025
Q3 		$45.7M Buy
2,263,400
+198,100
+10% +$3.48M 0.07% 283
2025
Q2 		$34.6M Buy
2,065,300
+964,100
+88% +$15.6M 0.06% 326
2025
Q1 		$16.9M Buy
1,101,200
+61,500
+6% +$1.1M 0.04% 498
2024
Q4 		$22.9M Buy
1,039,700
+660,100
+174% +$12M 0.05% 430
2024
Q3 		$6.84M Buy
379,600
+24,400
+7% +$427K 0.01% 951
2024
Q2 		$5.77M Buy
355,200
+33,900
+11% +$522K 0.01% 989
2024
Q1 		$4.53M Sell
321,300
-255,000
-44% -$3.21M 0.01% 1192
2023
Q4 		$6.02M Sell
576,300
-292,000
-34% -$2.73M 0.01% 1136
2023
Q3 		$8.86M Buy
868,300
+413,700
+91% +$3.85M 0.02% 750
2023
Q2 		$3.42M Buy
454,600
+93,800
+26% +$761K 0.01% 1246
2023
Q1 		$3.19M Buy
360,800
+217,700
+152% +$2.15M 0.01% 1373
2022
Q4 		$1.31M Sell
143,100
-152,100
-52% -$1.33M ﹤0.01% 2012
2022
Q3 		$2.38M Sell
295,200
-136,300
-32% -$1.21M 0.01% 1564
2022
Q2 		$3.25M Sell
431,500
-201,100
-32% -$1.75M 0.01% 1297
2022
Q1 		$5.94M Buy
632,600
+346,200
+121% +$2.89M 0.02% 896
2021
Q4 		$2.29M Buy
286,400
+76,400
+36% +$690K 0.01% 1514
2021
Q3 		$2.04M Sell
210,000
-95,300
-31% -$892K 0.01% 1605
2021
Q2 		$3.02M Buy
305,300
+49,900
+20% +$528K 0.01% 1159
2021
Q1 		$2.95M Sell
255,400
-211,800
-45% -$2.43M 0.01% 1028
2020
Q4 		$4.51M Buy
467,200
+178,000
+62% +$1.71M 0.02% 802
2020
Q3 		$2.61M Sell
289,200
-267,700
-48% -$2.83M 0.01% 949
2020
Q2 		$6.87M Sell
556,900
-85,500
-13% -$967K 0.04% 403
2020
Q1 		$5.77M Buy
642,400
+259,100
+68% +$2.65M 0.04% 343
2019
Q4 		$3.76M Buy
383,300
+184,000
+92% +$1.64M 0.03% 753
2019
Q3 		$1.37M Sell
199,300
-114,700
-37% -$879K 0.01% 1363
2019
Q2 		$2.9M Sell
314,000
-653,800
-68% -$7.88M 0.03% 783
2019
Q1 		$15.2M Buy
967,800
+402,800
+71% +$7.1M 0.12% 143
2018
Q4 		$8.71M Buy
565,000
+218,900
+63% +$4.49M 0.06% 261
2018
Q3 		$7.46M Sell
346,100
-17,100
-5% -$397K 0.04% 449
2018
Q2 		$8.83M Sell
363,200
-298,800
-45% -$6.09M 0.05% 330
2018
Q1 		$11.3M Buy
662,000
+239,900
+57% +$4.68M 0.06% 232
2017
Q4 		$8K Sell
422,100
-121,400
-22% -$1.83M 0.04% 430
2017
Q3 		$9.57K Sell
543,500
-94,100
-15% -$2.12M 0.05% 337
2017
Q2 		$21.2K Buy
637,600
+50,400
+9% +$1.56M 0.13% 104
2017
Q1 		$18.8K Buy
587,200
+141,800
+32% +$4.84M 0.13% 99
2016
Q4 		$16.2M Sell
445,400
-75,400
-14% -$3.01M 0.11% 100
2016
Q3 		$24M Buy
520,800
+423,000
+433% +$22.1M 0.16% 56
2016
Q2 		$4.91M Buy
97,800
+17,500
+22% +$932K 0.03% 463
2016
Q1 		$4.29M Sell
80,300
-505,100
-86% -$29.6M 0.04% 452
2015
Q4 		$38.4M Buy
585,400
+31,800
+6% +$1.97M 0.37% 29
2015
Q3 		$31.3M Buy
553,600
+113,200
+26% +$7.34M 0.29% 41
2015
Q2 		$26M Buy
440,400
+160,300
+57% +$9.89M 0.26% 47
2015
Q1 		$17.4M Buy
280,100
+260,500
+1,329% +$15.1M 0.18% 80
2014
Q4 		$1.13M Sell
19,600
-11,400
-37% -$635K 0.01% 963
2014
Q3 		$1.67M Buy
31,000
+21,800
+237% +$1.15M 0.02% 540
2014
Q2 		$481 Buy
9,200
+4,100
+80% +$210K 0.01% 1306
2014
Q1 		$270 Sell
5,100
-40,200
-89% -$1.86M ﹤0.01% 1710
2013
Q4 		$1.81M Buy
45,300
+2,700
+6% +$106K 0.02% 716
2013
Q3 		$1.61M Buy
42,600
+2,400
+6% +$93.6K 0.02% 641
2013
Q2 		$1.58M Buy
+40,200
New +$1.57M 0.02% 686

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's TEVA Position: Q1 2026 in Review

Walleye Trading reduced its Teva Pharmaceuticals (TEVA) stake by 6.3% in Q1 2026, selling an estimated $1.08M and leaving 499,536 shares worth $15M. The position accounts for 0.03% of the portfolio, ranked #617.

Walleye Trading first reported a position in TEVA in Q2 2013 and has held it in 32 quarters since. The position peaked at $22M in Q3 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Walleye Trading held 499,536 shares of Teva Pharmaceuticals worth $15M as of Q1 2026.
  • Walleye Trading sold 33,426 Teva Pharmaceuticals shares in Q1 2026, an estimated $1.08M.
  • Teva Pharmaceuticals made up 0.03% of Walleye Trading's portfolio in Q1 2026, its #617 holding.
  • Walleye Trading first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
  • Walleye Trading's Teva Pharmaceuticals position peaked at $22M in Q3 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.